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Results: Sim and weekly CBCT volumes were tested for non-
normality and leverage. 4 men had Sim volumes that were 
well in excess of 500mL, and by mid-course, had greatly 
reduced. The extreme cases exerted strong leverage. In 38 
men, bladder volumes were log-normally distributed. 
Compliant men had bladder volumes (162 mL) statistically 
significantly larger (p<0.01) than men refusing (83 mL). The 
random inter-fraction variation was the same in both groups 
(33%). Compliant men had a mean systematic increase in 
bladder volume of 12% (95%CI = 4.8-21%, p < 0.01) relative to 
Sim, compared to 32% (95%CI = 12%-55%, p < 0.01) in the 
refusing group. 
 
Conclusion: Systematic and random changes in bladder 
volume during PCa IGRT are relatively insensitive to bladder 
filling in PCa IGRT, provided the Sim volume is not excessive 
(> 500mL). Volumes at Sim are statistically significantly 
different between groups, so there may be implications for 
dose planning. We have proposed a follow-on project to 
measure the effect of changing the drinking instructions, so 
men are advised to drink and practice holding as much water 
as they can comfortably tolerate without voiding for 1 hour. 
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Purpose or Objective: Check of patients’ set-up is 
mandatory in modern radiation therapy. The aim of this 
preliminary analysis is to investigate the possibility to 
delegate to Radiation Therapists (RT) the evaluation of two- 
dimensional orthogonal kV/kV imaging of pelvic cancers. 
 
Material and Methods: Paired orthogonal kV images of 
patients who underwent pelvic irradiation were 
independently evaluated by a trained RT (on-line control) 
and a Radiation Oncologist (RO, off- line control). If a 
displacement of the isocenter larger than 5 mm was 
observed, the RT had to call the RO to verify and confirm 
such displacement. The difference of measures and the 
agreement between RO and RT decisions were calculated. 
Results are presented as mean values, and population 
systematic (Σ) and random (σ) errors. SPSS software was used 
for the statistical analysis. 
 
Results: From March 2015 to September 2015, 904 images’ 
pairs were obtained from 40 patients (10 prostate, 15 rectal, 
and 15 gynaecological cancers). A difference ≤ 3 mm was 
recorded in 766/904 (85%) paired images. A difference 
between 3 and 5 mm was recorded in 94/904 (10%) paired 
images. Forty-two/904 (4%) checks required on-line 
evaluation by the RO. In anteroposterior (AP), craniocaudal 
(CC) and mediolateral (ML) directions, systematic errors were 
0.7, 0.4 and 0.8 mm, and random error were 0.2, 0.1 and 0.1 
mm, respectively. Mean radial displacement was 2.6 mm 
(range 0-16 mm). CTV to PTV margins calculated by van 
Herk’s formula were 3.3, 2.3 and 3.0mm (AP, CC and ML 
directions, respectively). 
 
Conclusion: These data suggest that inter-observer 
variability between RT and RO is within few mm, therefore 
on-line kV/kV images’ evaluation could be delegated to RT 
after an adequate training period. Such kind of quantitative 
analysis can be used to define a proper action level to call for 
RO intervention. Similar study is currently ongoing to assess 
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Purpose or Objective: The current practice for prostate 
localisation in some centres is an automatic match to the 
bony anatomy of the pelvis. The prostate moves 
independently of bone and so its true motion may not be 
accounted with this method. An automatic match to the 
prostate may be more accurate. The purpose of this research 
it to identify if automatic prostate matching is more accurate 
than automatic bony matching and assess the impact on CTV-
PTV planning margins. 
 
Material and Methods: A retrospective review of CBCT data 
for 30 consented prostate patients was undertaken (9 CBCT 
each, n=270). All patients followed a bladder filling and 
rectal emptying protocol. Using Varian’s On-Board Imager® 
software, the random; systematic and population mean 
translational shifts was calculated based on 3 different 
registration techniques: automatic bone matching; automatic 
bone matching followed by an automatic volume of interest 
(VOI) match using CTV and an expert manual CTV match (gold 
standard). A comparison was made of the CTV-PTV margins 
required for the two automatic registration methods. 
 
Results: No significant difference in the mean translational 
shifts was reported between the automatic bone match and 
gold standard match. A significant difference was seen 
between the population mean shift of the gold standard 
match and the automatic prostate match in the 
anteroposterior direction only (p=0.007). A larger CTV-PTV 
margin was required for the automatic prostate match when 




Conclusion: Automatic bone matching is comparable to 
expert manual matching in this patient group. Automatic 
prostate matching is not as accurate in the anteroposterior 
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Purpose or Objective: The aim of the study is to evaluate 
the risk of late rectal bleeding and its association with 
anticoagulants and/or antiaggregants use in patients 
receiving radiation therapy for prostate cancer. 
 
Material and Methods: We analyzed 187 patients, age 
between 50-84, with prostate cancer who were managed 
from 2009 to 2011 at our institution. They were treated with 
curative intent intensity-modulated radiation therapy (IMRT 
76 Gy/38 fractions) at the level of the prostate and seminal 
vesicles. The doses delivered to the rectum was evaluated in 
a manner consistent with ICRU 50-62-83. Dose constraint 
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evaluation was performed according to RTOG 
recommendation for IMRT. Patients were placed in two main 
categories: no anticoagulants and/or antiaggregants use 
category during RT and anticoagulants and/or antiaggregants 
one. Rectal toxicity was evaluated using the Common 
Toxicity Criteria Adverse Effect (CTCAE v. 4.03) All patients 
had assumed the anticoagulant and/or antiaggregant therapy 
before radiation therapy, during treatment as well as during 
the follow up. 
 
Results: 20 of the 73 patients treated with anticoagulant 
and/or antiaggregant therapy, presented rectal bleeding; 
while in the group of patients not taking anticoagulants 
and/or antiaggregants this even occurred in 10 patients of 
114 (p<0.001). Of the 20 patients who have received 
anticoagulant and/or antiaggregant agent who presented 
rectal bleeding, 8 developed G1 toxicity, 10 had G2 toxicity 
and 2 patients had G3 toxicity. Of the 10 patients who did 
not receive anticoagulant and antiaggregant therapy and 
presented rectal bleeding, 5 patients had G1 toxicity, 4 
present G2 toxicity and G3 toxicity only 1 patient. 
 
Conclusion: The results of our study found that patients 
taking anticoagulant and/or antiaggregants therapy 
undergoing curative radiotherapy for prostate 
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Purpose or Objective: Stereotactic radiotherapy of liver 
metastases is challenging: breathing motion, and the 
flexibility of the abdominal organs, in particular remaining 
liver, may be large. This may render a priori imaging for 
position verification virtually useless. Hence, "decision to 
treat" may be difficult and stressful.  
Abdominal compression may be used to reduce movement 
and flexibility, but maximum compression is highly 
uncomfortable and probably intolerable for patients during 
the entire session (20-30 min). Our institution has chosen to 
limit compression so that patients can endure it easily during 
the entire session. This study investigates whether this type 
of abdominal compression is effective. 
 
Material and Methods: In short, a diagnostic 2 phase CT scan 
was used to locate tumor positions. Belt pressure and 
marking position (Orfit Industries), were reproduced for each 
treatment fraction. Each fraction, cone beam CTs (CBCT) 
were recorded before and immediately afterwards. Scans 
were matched offline, using deformable image registration 
(Varian Smart Adapt V13), resulting in “CBCT liver contours”. 
These were checked and adjusted, if necessary.  
Each CBCT liver contour was compared to original CT contour 
using absolute volume, center of mass shift (CMS) and dice 
coefficient (DC). To assess effectiveness of compression, data 
were averaged for each of the three computed parameters. 
 
Results: Until this date, a total of 6 patients were treated 
using this technique. All 6 tolerated the applied abdominal 
compression easily during the sessions. Therapists, trained in 
>> 100 brain or lung stereotactic treatments, reported no 
exceptional difficulties in fixation, CBCT, and matching.  
Data from 4 patients, and a total of 24 CBCTs, were eligible 
for analyses. Liver CBCT volumes appeared to be very similar 
to CT contours: the average is only 18 cc less, with a 
maximum of 116 cc. The average CMS in X, Y, Z are 0.14cm 
(max 0.41cm), 0.05cm (max 0.33cm) and 0cm (max 0.23cm), 
respectively. Average DC is 0.94, with a range of [0.89 0.99].  
 
Conclusion: Difference in volume, center of mass, and even 
shape are well within the range of standard uncertainties in 
stereotactic abdominal radiotherapy. This corroborates with 
the reported feasibility by therapists treating these patients.  
In short, the patient comfortable setting of the compression-
belt is reproducible and safe to correctly deliver the dose in 
stereotactic radiotherapy of the liver.  
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Purpose or Objective: Prostate cancer patients often find it 
difficult to maintain a full bladder throughout the course of 
their radiotherapy treatment. These bladder filling problems 
can result in patients being taken out of the treatment room 
in order to increase bladder filling, leading to treatment 
delays. The aim of this study was to provide a range of 
acceptable bladder sizes without compromising the bladder 
dose constraints. 
Material and Methods: An audit was carried out with ten 
patients who attended for IMRT radiotherapy planning for 
prostate cancer. A minimum bladder volume (bladder min) in 
each patient was defined by cropping the planning CT (pCT) 
bladder volume to around 150cc. This new volume was then 
used in addition to the pCT bladder volume in the IMRT plan 
optimisation to fulfil the bladder dose constraints. The 
patients had their bladder volume assessed prior to 
treatment using a standard CBCT imaging protocol. 
Retrospective dose calculations were undertaken using the 
daily CBCT images, and bladder doses were plotted against 
bladder volume to demonstrate that dose constraints were 
still being met at the reduced bladder volume. The tolerance 
doses used are taken from the CHHiP trial protocol. 
 
Results: The bladder min contour is used by the treatment 
radiographers as a visual guide on the CBCT scan taken 
before each treatment in order to assess whether the 
patient’s bladder is an acceptable size to continue with 
treatment without compromising bladder tolerance doses. 
The volume of the bladder min contour is adjusted to meet 
the constraints for each individual patient as necessary 
The need for patients to be taken out of the treatment room 
to re-fill the bladder has been reduced and this has resulted 
in better workflow on the treatment floor. The use of the 
bladder min contour for prostate IMRT treatment planning is 
now standard practice in our clinic. 
 
Conclusion: The use of the bladder min contour has improved 
patient comfort without compromising the therapeutic ratio 
and has aided the radiographers in online review of 
treatment images. 
The implementation of the above has led to a reduction in 
treatment delays due to the bladder volume obtained at 
planning CT not being maintained throughout treatment. This 
has improved the clinic workflow. Patient discomfort is kept 
to a minimum and repeat CBCT scans have been reduced. 
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Purpose or Objective: The aim of the study was an analysis 
of an influence of type and intensity of pts anxiety on pts 
repositioning during planning and delivery of RT to the pelvic 
area in relation to pts gender, immobilization device, and 
